UniCredit Reports Strong Third-Quarter Earnings, Raises 2023 Guidance

1 Mins read

UniCredit, the Italian bank, has reported a rise in earnings for the third quarter, exceeding analyst expectations. The bank’s performance was driven by net interest income, leading to an increase in its 2023 guidance.

Financial Results

During the period, UniCredit achieved a net profit of €2.32 billion ($2.48 billion), compared with €1.71 billion in the same period last year. The bank’s revenue also grew by 24% year-on-year, reaching €5.97 billion.

UniCredit saw a 2.9% increase in net interest income in the third quarter compared to the previous quarter, reaching €3.6 billion. This represents a significant growth of 45% compared to the same period last year.

Beating Expectations

Analysts had predicted a net profit of €1.92 billion, net interest income of €3.5 billion, and revenue of €5.74 billion. However, UniCredit’s actual results surpassed these estimates, according to a bank-provided consensus of analysts’ average expectations.

Operational Costs and Guidance

UniCredit’s operational costs remained flat in the third quarter compared to the previous quarter and decreased by 2.3% compared to the same period last year.

Additionally, UniCredit raised its 2023 guidance for net interest income to at least €13.7 billion from the previous forecast of at least €13.2 billion. The bank also increased its outlook for 2023 net revenue to above €22.2 billion, up from above €21.5 billion.

Furthermore, UniCredit expects a net profit of at least €7.25 billion and plans to distribute at least €6.5 billion to its shareholders in 2024.

These positive results indicate UniCredit’s strong financial performance and its ability to deliver value to its shareholders.

Related posts

GitLab Stock Surges on First Ever Adjusted Operating Profit

1 Mins read
GitLab’s stock experienced a significant surge on Tuesday following the announcement of its first ever adjusted operating profit. Despite this positive development,…

Virgin Galactic Faces Stock Decline Amid Founder's Money Decision

2 Mins read
Virgin Galactic stock experienced a sharp decline in early trading on Monday due to founder Richard Branson’s announcement that he won’t be…

EyePoint Pharmaceuticals Announces Positive Results in Phase 2 Trial for Macular Degeneration Treatment

1 Mins read
EyePoint Pharmaceuticals, a Massachusetts-based company, revealed exciting news on Monday regarding the second-phase trial of its investigational treatment for macular degeneration. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

− 1 = 2